Investigating the diagnostic and management practices for canine myxomatous mitral valve disease in Australia using clinical vignettes

Abstract Background Canine myxomatous mitral valve disease (MMVD) is the most common heart disease of dogs, accounting for approximately 75% of canine heart disease cases. The latest iteration of the American College of Veterinary Internal Medicine (ACVIM) guidelines on this topic marked a significant change in management recommendations from a previous “watch and wait” approach for preclinical MMVD to recommending treatment with pimobendan for all dogs with Stage B2 MMVD. Little is currently known about the utilisation of these guidelines by veterinarians in general practice in Australia. The current study aimed to investigate the diagnosis, staging and management of MMVD by veterinarians in general practice in Australia utilising a series of four clinical vignettes, including their familiarity with, and accessibility to, various cardiology diagnostic techniques. Results The data from 319 valid responses were analysed. A significantly greater proportion of respondents correctly staged the clinical case as Stage C compared to preclinical vignettes. Regarding treatment of preclinical disease, only 47.3% of total respondents recommended treatment for Stage B2 disease in line with ACVIM recommendation. In managing Stage B2 disease, veterinarians were more likely to recommend treatment when the murmur was graded as high (72.4%) compared to mild (47.3%) for a similarly staged dog. Conclusions This survey demonstrated that whilst most veterinarians are making recommendations in line with accepted international guidelines for MMVD, there is scope to improve diagnostic, staging and treatment protocols in general practice in Australia, particularly in preclinical patients. Two main barriers to correctly stage, and therefore correctly treat, a preclinical patient were identified. Firstly, a significant proportion of veterinarians are opting to monitor asymptomatic patients with a heart murmur rather than recommending a diagnostic investigation and secondly, the ability to accurately stage preclinical patients according to the ACVIM guidelines once imaging has been performed.

Authors

Institutions

Publication Details

Journal
BMC Veterinary Research
Published
2026-11-12
DOI
https://doi.org/10.1186/s12917-026-06064-9
Primary Topic
Veterinary Medicine and Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Investigating the diagnostic and management practices for canine myxomatous mitral valve disease in Australia using clinical vignettes

Jane Heller, Eve Perry, Phillip McDonagh
BMC Veterinary Research
Veterinary Medicine and Surgery
article

Investigating the diagnostic and management practices for canine myxomatous mitral valve disease in Australia using clinical vignettes

Jane Heller, Eve Perry, Phillip McDonagh
article en

Abstract

Abstract Background Canine myxomatous mitral valve disease (MMVD) is the most common heart disease of dogs, accounting for approximately 75% of canine heart disease cases. The latest iteration of the American College of Veterinary Internal Medicine (ACVIM) guidelines on this topic marked a significant change in management recommendations from a previous “watch and wait” approach for preclinical MMVD to recommending treatment with pimobendan for all dogs with Stage B2 MMVD. Little is currently known about the utilisation of these guidelines by veterinarians in general practice in Australia. The current study aimed to investigate the diagnosis, staging and management of MMVD by veterinarians in general practice in Australia utilising a series of four clinical vignettes, including their familiarity with, and accessibility to, various cardiology diagnostic techniques. Results The data from 319 valid responses were analysed. A significantly greater proportion of respondents correctly staged the clinical case as Stage C compared to preclinical vignettes. Regarding treatment of preclinical disease, only 47.3% of total respondents recommended treatment for Stage B2 disease in line with ACVIM recommendation. In managing Stage B2 disease, veterinarians were more likely to recommend treatment when the murmur was graded as high (72.4%) compared to mild (47.3%) for a similarly staged dog. Conclusions This survey demonstrated that whilst most veterinarians are making recommendations in line with accepted international guidelines for MMVD, there is scope to improve diagnostic, staging and treatment protocols in general practice in Australia, particularly in preclinical patients. Two main barriers to correctly stage, and therefore correctly treat, a preclinical patient were identified. Firstly, a significant proportion of veterinarians are opting to monitor asymptomatic patients with a heart murmur rather than recommending a diagnostic investigation and secondly, the ability to accurately stage preclinical patients according to the ACVIM guidelines once imaging has been performed.

BMC Veterinary Research
Charles Sturt University (AU), Boehringer Ingelheim (Australia) (AU)
Good health and well-being
Veterinary Medicine and Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon